Symbio Research
Samantha Waddell, MPH, currently serves as an Associate Clinical Project Manager at Symbio Research since April 2023. Previously, Waddell worked as a Project Coordinator and Summer Intern on the Prospective Studies Team at Xcenda from June 2021 to April 2023. Prior experience includes serving as an Undergraduate Research Assistant at the Department of Obstetrics, Gynecology & Reproductive Science at the Miller School of Medicine, where responsibilities included patient recruitment and conducting focus groups from August 2018 to June 2021. Additionally, Waddell worked as a Biology Peer Advisor at the Office of Science Advising at the University of Miami, supporting first-year students from August 2017 to April 2020, and as an Undergraduate Research Assistant at Yale University School of Medicine, assisting with lab procedures in May to July 2017. Waddell holds a Master of Public Health in Population Health Research from Case Western Reserve University and a Bachelor's degree in Marine Science and Biology from the University of Miami Rosenstiel School of Marine, Atmospheric and Earth Science.
This person is not in any offices
Symbio Research
Headquartered in Port Jefferson, NY, Symbio is a client-focused global full service Clinical Research Organization (CRO). We manage all CRO core services in house and have our offices in the USA and Europe. We deliver excellent service and provide experienced qualified personnel to strategically manage all aspects of your clinical trials. Symbio offers expertise in Proof-of-Concept, medical device and Phase I – Phase IV clinical studies and has completed over 115 clinical studies to date, both in the USA and in other territories. Developing and maintaining excellent relationships with experienced clinical research sites are vital to the success of any study and every CRO. As a direct result of our site relationships, Symbio trials receive the special attention they deserve. We take great pride in the strong relationships we have established through the years. These relationships have provided us the ability to streamline recruitment, creating shorter enrollment timelines with a lower number of sites. Our expertise starts from the top. Symbio, LLC was founded in 2002 by Richard Panico and Debra Dow. With previous leadership roles in CRO management and product development, Rich and Deb have been able to successfully grow their company by carefully selecting qualified clinical research professionals. In collaboration with senior management, their continued oversight offers clients a personalized experience ensuring study management challenges are anticipated, identified and resolved quickly and efficiently. In 2018 Richard Panico, Debra Dow and Veronika Kunert founded Symbio’s subsidiary in Europe to support our clients with their global clinical trials. The vision from the start has been to create a CRO that consistently delivers outstanding service and quality to sponsors. The common goal is to bring clinical studies to a successful end, on time and on budget.